1. Home >
  2. Companies >
  3. Acquired >
  4. Medical Products >
  5. United States >
  6. New Jersey >
  7. Watson Pharmaceuticals >
  8. M&A

Watson Pharmaceuticals Mergers & Acquisitions

Watson Pharmaceuticals M&A Summary

Watson Pharmaceuticals has acquired 9 companies of its own. It has also divested 1 asset.

Watson Pharmaceuticals’ largest acquisition to date was in 2012, when it acquired Pharmaco Hf. for $4.8B. Watson Pharmaceuticals has acquired in 2 different US states, and 8 countries. The Company’s most targeted sectors include life science (56%) and medical products (45%).

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity9
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 5

Watson Pharmaceuticals, Inc.

100 Campus Drive,
Florham Park, New Jersey 07932
United States,
(201) 593-5500
www.actavis.com

All (10) Buy (9) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2013-01-23 Uteron Pharma SA · Medical Products
Grâce-Hollogne, Belgium · www.uteron.com

Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.

150 Add-on Acquisition

Watson Pharmaceuticals, Inc.

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal